Current Status and Future Directions in Appendiceal Cancer with Peritoneal Dissemination

Surgical Oncology Clinics of North America

Volumn 21, Issue 4, 2012, Pages 599-609

  Votanopoulos, Konstantinos I ^a   Shen, Perry ^a   Stewart, John H ^a   Levine, Edward A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Appendiceal cancer; Chemotherapy; Hyperthermic intraperitoneal perfusion; Peritoneal surface disease; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

APPENDIX CANCER; CANCER GRADING; CANCER SURGERY; CANCER SURVIVAL; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; ENDOSCOPY; HUMAN; HYPERTHERMIC THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT SELECTION; PERITONEUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIMARY TUMOR; REVIEW; SENSITIVITY AND SPECIFICITY;

APPENDICEAL NEOPLASMS; CARCINOMA; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HUMANS; HYPERTHERMIA, INDUCED; PERITONEAL NEOPLASMS; PREOPERATIVE CARE;

EID: 84866776574     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2012.07.012     Document Type: Review

References (47)

1. Collins D.C. 71,000 human appendix specimens. A final report, summarizing forty years' study. Am J Proctol 1963, 14:265-281.
2. McCusker M.E., Cote T.R., Clegg L.X., et al. Primary malignant neoplasms of the appendix: a population-based study from the Surveillance, Epidemiology and End-Results program, 1973-1998. Cancer 2002, 94(12):3307-3312.
3. Gough D.B., Donohue J.H., Schutt A.J., et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994, 219(2):112-119.
4. Foster J.M., Gupta P.K., Carreau J.H., et al. Right hemicolectomy is not routinely indicated in pseudomyxoma peritonei. Am Surg 2012, 78(2):171-177.
5. Chua T.C., Al-Zahrani A., Saxena A., et al. Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation. J Am Coll Surg 2010, 211(4):526-535.
6. Miner T.J., Shia J., Jaques D.P., et al. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 2005, 241(2):300-308.
7. Spratt J., Adcock M., Miskovin M., et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980, 40:256-260.
8. Sugarbaker P.H., Landy D., Pascal R. Intraperitoneal chemotherapy for peritoneal carcinomatosis from colonic or appendiceal cystadenocarcinoma: rationale and results of treatment. Prog Clin Biol Res 1990, 354B:141-170.
9. Sugarbaker P.H., Kern K., Lack E. Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment. Dis Colon Rectum 1987, 30(10):772-779.
10. Farquharson A.L., Pranesh N., Witham G., et al. A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei. Br J Cancer 2008, 99(4):591-596.
11. Lieu C.H., Lambert L.A., Wolff R.A., et al. Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol 2012, 23(3):652-658.
12. Sugarbaker P.H., Bijelic L., Chang D., et al. Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin. J Surg Oncol 2010, 102(6):576-581.
13. Sindelar W.F., DeLaney T.F., Tochner Z., et al. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study. Arch Surg 1991, 126(3):318-324.
14. Votanopoulos K.I., Ihemelandu C., Shen P., et al. Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg 2012, 215(3):412-417.
15. Chua T.C., Moran B.J., Sugarbaker P.H., et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012, 30(20):2449-2456.
16. de B.E., Koops W., Kroger R., et al. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 2004, 86(2):64-73.
17. Dromain C., Leboulleux S., Auperin A., et al. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging 2008, 33(1):87-93.
18. Low R.N., Barone R.M., Gurney J.M., et al. Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings. AJR Am J Roentgenol 2008, 190(3):656-665.
19. Sobhani I., Tiret E., Lebtahi R., et al. Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer. Br J Cancer 2008, 98(5):875-880.
20. Rohani P., Scotti S.D., Shen P., et al. Use of FDG-PET imaging for patients with disseminated cancer of the appendix. Am Surg 2010, 76(12):1338-1344.
21. Trivedi A.N., Levine E.A., Mishra G. Adenocarcinoma of the appendix is rarely detected by colonoscopy. J Gastrointest Surg 2009, 13(4):668-675.
22. Ross A., Sardi A., Nieroda C., et al. Clinical utility of elevated tumor markers in patients with disseminated appendiceal malignancies treated by cytoreductive surgery and HIPEC. Eur J Surg Oncol 2010, 36(8):772-776.
23. Elias D., Gilly F., Quenet F., et al. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 2010, 36(5):456-462.
24. Smeenk R.M., Verwaal V.J., Antonini N., et al. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 2007, 245(1):104-109.
25. Ronnett B.M., Zahn C.M., Kurman R.J., et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei." Am J Surg Pathol 1995, 19(12):1390-1408.
26. Bradley R.F., Stewart J.H., Russell G.B., et al. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 2006, 30(5):551-559.
27. Misdraji J., Yantiss R.K., Graeme-Cook F.M., et al. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 2003, 27(8):1089-1103.
28. El H.H., Gushchin V., Francis J., et al. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol 2012, 19(1):110-114.
29. Stewart J.H., Shen P., Russell G.B., et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol 2006, 13(5):624-634.
30. Levine E.A., Blazer D.G., Kim M.K., et al. Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. J Am Coll Surg 2012, 214(4):599-606.
31. Sugarbaker P.H., Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999, 6(8):727-731.
32. Elias D., Laurent S., Antoun S., et al. Gastroenterol Clin Biol 2003, 27(4):407-412. [in French].
33. Deraco M., Baratti D., Inglese M.G., et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 2004, 11(4):393-398.
34. Yan T.D., Links M., Xu Z.Y., et al. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms. Br J Surg 2006, 93(10):1270-1276.
35. Chua T.C., Yan T.D., Smigielski M.E., et al. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol 2009, 16(7):1903-1911.
36. Halabi H.E., Gushchin V., Francis J., et al. Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer. Ann Surg Oncol 2012, 19(1):122-125.
37. Gonzalez-Moreno S., Brun E., Sugarbaker P.H. Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2005, 12(1):72-80.
38. Shen P., Levine E.A., Hall J., et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003, 138(1):26-33.
39. Stewart J.H., Shen P., Levine E.A. Patient selection for cytoreduction and hyperthermic intraperitoneal chemoperfusion. Cancer Treat Res 2007, 134:215-229.
40. Esquivel J., Sugarbaker P.H. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients. Ann Surg 2001, 234(2):198-205.
41. Elias D., Honore C., Ciuchendea R., et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg 2008, 95(9):1164-1171.
42. Loungnarath R., Causeret S., Bossard N., et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum 2005, 48(7):1372-1379.
43. Sugarbaker P.H., Alderman R., Edwards G., et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 2006, 13(5):635-644.
44. Witkamp A.J., de B.E., Kaag M.M., et al. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001, 88(3):458-463.
45. Kusamura S., Baratti D., Deraco M. Multidimensional analysis of learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Ann Surg 2011, 255(2):348-356.
46. Levine E.A., Stewart J.H., Russell G.B., et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg 2007, 204:943-955.
47. Elias D. Is intraperitoneal chemotherapy after cytoreductive surgery efficient? Knowing whether it is or not appears secondary!. Ann Surg Oncol 2011, 19(1):5-6.